Benzodiazepine Detox for New York Residents

Why I Built a Program for This

Holistic Sanctuary wasn’t created from a business plan. It was created from a failure — mine, and the system’s. I spent years cycling through treatment that managed me and never restored me, and I came out the other side asking the one question every person who calls us from New York is already asking: why does the system meant to help people send so many of them home worse than it found them?

New York is where I hear that question asked most often, and most articulately. The people who call us from Manhattan, Westchester and Long Island have usually already done everything the system offered: the outpatient taper that stalled, the short detox admission that sent them home fragile, the prescriber who was willing to reduce but had no way to supervise what happened next. They are not looking for a pep talk. They are looking for someone who will tell them what actually happens and why.

We opened in 2011. More than 1,000 clients have come through since, and I would rather you hear that number from me with its limits attached: it is not a success rate, it is not proof of anything for you personally, and I will not use it that way. It is fifteen years of one-to-one work, adjusted case by case, with a founder who stayed in the room. That is the only credential behind what follows.

How People in New York End Up Here

Practically nobody sets out to become dependent on a benzodiazepine. The story is nearly always the same, and it almost never involves a bad decision.

There was a period of acute anxiety, or panic, or insomnia, or grief. A prescription was written — often for two weeks, often by a doctor acting entirely reasonably. Then the two weeks were renewed. Then the dose stopped holding, so it went up.

Then the person discovered that the space between doses had started to feel worse than the original problem ever did, and that discovery arrived without anyone having warned them it was coming.

By the time people contact us from New York, the story is usually measured in years rather than months. Many have already tried to come off, twice or three times. Each attempt ended the same way: symptoms that were unbearable, no supervision to get through them, and a return to the dose out of sheer necessity.

I have heard this story more times than I can count, and I want to say something plainly to anyone reading it about themselves: that is not weakness, and it is not a character problem. It is pharmacology.

What New York’s Prescribing Rules Changed — and What They Did Not

New York was early to tighten prescription monitoring. Effective 27 August 2013, most prescribers in the state have been required to consult the Prescription Monitoring Program Registry before writing a prescription for a Schedule II, III or IV controlled substance. Benzodiazepines sit in Schedule IV, so they are covered.

The rule did what it was designed to do. It made duplicate prescribing visible, and it made it considerably harder for someone to collect the same medication from several practices at once.

What it did not do was help the person who was already dependent after taking exactly what one doctor prescribed.

That is the situation most New Yorkers describe to me. Nothing was hidden. There was one prescriber, one pharmacy and one medication, taken as directed, and the dependence formed anyway. Tighter monitoring does not reverse a nervous system that has already adapted to the drug, and it does not supply the thing that reduction actually requires: supervision, time, and somewhere to be while the reduction is happening.

In practice a monitored prescription can even make the reduction harder to start, because a person who is tapering is now visible in a registry and worries about how that looks. It is worth saying plainly that being on a monitored medication is not a mark against anyone. It is a prescription record. It records that a controlled medication was prescribed and dispensed. It does not record a judgment about the person, it is not visible to an employer, and it does not follow anyone into a treatment decision made with their own physician. I mention it only because it comes up in almost every conversation I have with someone calling from New York.

Then there is the federal picture. On 23 September 2020 the FDA required an updated boxed warning across the entire benzodiazepine class, stating that physical dependence can develop after several days to weeks of steady use at prescribed doses, that abrupt discontinuation can produce life-threatening withdrawal reactions including seizures, and that withdrawal symptoms can persist for weeks to more than twelve months. In its 2020 review the agency counted roughly 92 million benzodiazepine prescriptions dispensed in the United States in 2019. New York’s registry had been running for seven years by then. Monitoring who gets the prescription and warning people what the prescription does turned out to be two very different things.

Why Coming Off Is So Much Harder Than Going On

Benzodiazepines act on the GABA system, the brain’s primary braking mechanism. Sustained use changes how that system responds. When the drug is reduced, the braking capacity that has been chemically outsourced is not immediately available again, and the result is the familiar spectrum of withdrawal: rebound anxiety well beyond the original, insomnia, tremor, sensory hypersensitivity, derealization, and in severe cases seizures.

This is why prescribing guidance treats benzodiazepine discontinuation as something to be done gradually and under supervision, and why the standard outpatient answer is a taper measured in many months. That advice exists for good reason, and I am not going to tell you it is wrong.

The difficulty is what it looks like for the person living it: a very long stretch of time spent partly symptomatic, alone, still working, still parenting, still commuting on the 6 train, and repeatedly deciding whether today is the day to hold the reduction or go back up.

I will also say what the science makes plain and what nobody tells people: effort is not a variable here. The receptor changes that make a reduction hard are the same in the surgeon and the schoolteacher. Wanting it more does not change the chemistry.

What the Withdrawal Actually Looks Like

There is no single presentation, and anyone who publishes a day-by-day chart is describing an average rather than a person. What the clinical literature does describe consistently is a set of domains that tend to be affected together.

Autonomic and physical. Tremor, sweating, palpitations, elevated heart rate and blood pressure, nausea, muscle pain and stiffness, headache, and in severe cases seizures.

Sleep. Insomnia that is often worse than whatever the prescription was originally written for, along with vivid or disturbing dreams.

Anxiety and mood. Rebound anxiety and panic beyond the original baseline, irritability, low mood, and emotional volatility.

Sensory and cognitive. Hypersensitivity to light, sound and touch; tinnitus; difficulty concentrating; memory complaints; and derealization or depersonalization, which people frequently find the most frightening symptom of all because it is the one nobody warned them about.

Two points are worth stating plainly, because they are where most of the harm happens.

The first is that severity does not track neatly with dose. People on comparatively small daily doses, taken for years, can have a difficult reduction. Being on “only” a low dose is not a reason to assume this will be simple.

The second is that protracted symptoms are real. A 2023 survey of 1,207 benzodiazepine users published in PLOS ONE — the BIND study — found that 76.6 percent of symptom reports lasted months or more than a year, and that more than 90 percent of respondents described at least one serious life consequence. It was a self-selected internet survey with no control group, and I say that because you deserve to know the limits of every number on this page. But it is consistent with the FDA’s own language, and it is consistent with what I have watched people go through for fifteen years. This is documented, it is not imagined, and it is not a sign that someone is doing it wrong.

None of this is an argument for staying on the medication. It is an argument for coming off it somewhere with a physician on site.

What Benzodiazepine Detox for New York Residents Actually Involves Here

The taper is inpatient and medically supervised from the first day to the last, with nursing cover running 24 hours a day across a morning shift, an evening shift and two to three night shifts, with at least four nurses on duty across a 24-hour period.

Dr. Jose A. Jimenez, MD, our Medical Director, reviews and clears each client before treatment begins and signs off on the medical picture the taper is built on. I am not a physician and I do not pretend to be one; he is, and every clinical decision on this page runs through him.

It begins with a full workup: bloodwork, EKG, cardiac evaluation, and an honest accounting of everything currently in the system, including alcohol, opioids and other prescriptions. Polypharmacy is the norm rather than the exception among the people who come to us, and it changes the plan.

From there the reduction is stepwise and continuously monitored, slowed whenever the clinical picture calls for it. The schedule is set and adjusted clinically, based on the person in front of us rather than a printed timetable. Sleep, nutrition, hydration and autonomic symptoms are managed around the clock rather than left to the guest to endure between appointments.

What we do not do is substitute. Nobody leaves here on a maintenance prescription for something else, and nobody is moved sideways onto a longer-acting drug they will have to come off in a year’s time somewhere else. I have watched that pattern for fifteen years — a person “successfully” off one benzodiazepine and quietly on another — and I refuse to run it here.

Medication-free is the destination. If that is not what someone wants, we are the wrong facility, and we say so during the inquiry.

The taper also happens here, in-house. It is not outsourced to a detox unit elsewhere and then handed back to us afterwards.

Why Twelve Weeks, Not Less

I hear the objection before it’s finished: twelve weeks is a long time to be away from a life. I understand that completely. What I have also seen, in this field for fifteen years, is what happens when a timeline is compressed to fit a calendar instead of a body.

The standard outpatient answer to benzodiazepine dependence is a taper measured in many months, sometimes years. That advice exists for good reason, and I am not going to tell you it is wrong. The difficulty is what it looks like for the person living it: a very long stretch of time spent partly symptomatic, alone, still working, still parenting, still driving, and repeatedly deciding whether today is the day to hold the reduction or go back up.

Carrying out a reduction inside a facility, with 24-hour nursing cover, continuous monitoring and full-time support, changes what a person is able to tolerate — and therefore changes what is achievable in a given stretch of time.

Programs here run four to twelve weeks, and longer when a taper needs it. We do not run a five-to-seven-day detox, because a week is long enough to get someone through the sharpest edge of withdrawal and send them home fragile, which is how people end up back on the prescription within the month.

Twelve weeks is the floor, not a target we hit early when things go well. Some tapers here run slower than expected because the clinical picture demands it, and we would rather extend a stay than hit a date. It also does not mean this is easy. It means it is supervised, and that the hardest part happens somewhere with a physician on site rather than in a bedroom at four in the morning.

What Each Therapy Does — and What the Research Actually Shows

I built this section because I’m tired of watching this industry either oversell every therapy as a miracle or say nothing real about any of them. Below is what the published research says about each modality that runs alongside a benzodiazepine taper here — general findings from clinical and scientific literature, not claims about outcomes at this facility or for any individual guest. Where the evidence is strong, I say so. Where it’s early or mixed, I say that too.

One thing first. The reduction schedule is the spine of the program. Everything below exists to make that schedule survivable. None of it replaces it, and no component of this program has been tested in a randomized controlled trial as a treatment for benzodiazepine dependency. I am not going to imply otherwise.

The Brain Repair IV Protocol

The Brain Repair IV Drip is a proprietary formulation I developed myself, incorporating amino acids, peptides and a nature-derived alkaloid. It is the intravenous component of the Pouyan Method built for benzodiazepine and SSRI recovery, sequenced and dosed to the individual under nursing supervision. It is one component of a comprehensive, individualized protocol, intended to support the body and brain during the recovery process rather than presented as a guaranteed cure or a replacement for individualized medical care. The formulation, administration sequence and available evidence are documented separately on our Brain Repair IV Protocol page.

NAD+ Support and Amino Acids

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme every cell in the body requires for energy metabolism, and levels are known to decline with age and with chronic substance use. NAD+ and amino acid support are used here to assist the body’s own restorative processes during a period of significant physical demand. This is an area where clinical research is still developing, and we do not claim it treats any specific condition. I will also say directly what I make every member of staff say: NAD is a supportive therapy here. It is not the Brain Repair Protocol, and I do not allow it to be described as if it were.

Hyperbaric Oxygen Therapy (HBOT)

HBOT increases the amount of oxygen dissolved in blood plasma by having a person breathe oxygen at elevated atmospheric pressure. A 2024 review in Frontiers in Neurology describes how this process can promote mitochondrial function, new blood vessel growth, and reduced inflammatory signaling (lower TNF-α and IL-6) in nervous system tissue. HBOT is FDA-cleared for a specific list of conditions — wound healing, decompression sickness and carbon monoxide poisoning among them — and the Undersea and Hyperbaric Medical Society’s approved indications do not include benzodiazepine dependency. Its use for neurological and psychiatric conditions remains an active area of research rather than an approved indication. At Holistic Sanctuary, it is offered as a supportive therapy within a broader protocol, not as a treatment for any diagnosis on its own.

Red Light Therapy and Infrared Sauna

Red and near-infrared light in the 600–1,100 nanometer range is absorbed by an enzyme called cytochrome c oxidase inside mitochondria, increasing cellular ATP production — a mechanism reviewed extensively by Harvard-affiliated researcher Michael Hamblin. This is the basis for red light therapy’s documented effects on collagen production, wound healing and inflammation at the cellular level. Infrared sauna use operates differently, through heat: a study published in JAMA Internal Medicine associated frequent sauna use with reduced cardiovascular risk, and infrared heat exposure has been shown to activate heat shock proteins involved in cellular repair and to promote sweat-based excretion of certain heavy metals and organic compounds. Both are offered here as restorative, supportive therapies — not as treatments for any specific disease.

Therapeutic Massage

A widely cited review by Tiffany Field and colleagues, published in the International Journal of Neuroscience, found that massage therapy was associated with an average 31% decrease in cortisol and increases of 28% in serotonin and 31% in dopamine across a range of populations and conditions, including stress, pain and mood-related studies. In a benzodiazepine taper, where the nervous system is being asked to do without a brake it has leaned on for years, that matters. Massage is included as bodywork that supports the nervous system during an intensive period of change — not as a treatment for any underlying condition.

Yoga, Breathwork and Meditation

A systematic review in Health Psychology Review examined the mechanisms by which yoga reduces stress and found consistent evidence for effects on cortisol, inflammatory markers (IL-6, C-reactive protein) and psychological measures including self-compassion and positive affect. A separate controlled study of medical students found a statistically significant reduction in perceived stress after six weeks of yoga and meditation practice. These practices are part of daily life here because the evidence for their effect on stress physiology is genuinely strong — not because we present them as a cure for anything.

Detox Baths, Juice Cleanses, Superfoods and Organic Nutrition

The nutritional program is built around what your body specifically needs to rebuild during a taper — not a generic cleanse. Real, whole-food, organic nutrition supporting liver function and cellular repair is foundational to every other therapy in this program; a depleted body cannot make full use of any of the modalities above it. Detox baths, juice cleanses and superfood nutrition sit in the same category: supportive, restorative, and honestly described as such.

How These Are Scheduled

Nothing here runs on a fixed weekly timetable that every guest moves through together. Sessions are placed around where a person is in their reduction — heavier support in the days after a step down, lighter when a dose is holding steady — and the physician can pause any of it. If a therapy is not appropriate for someone on the day, it does not happen on the day, and nothing about the reduction schedule changes because of it. The taper is the fixed point; everything else moves around it.

Traveling from New York

Most people who reach us from New York have already exhausted the options within reach of home: an outpatient taper that stalled, a short detox admission that sent them back fragile, or a prescriber who was willing to reduce but had no way to supervise what happened next.

Travel is a real consideration and we treat it as one. The medical clearance happens before anyone books, because the workup determines whether an inpatient reduction is appropriate at all. If it is not, we say so. Nobody flies down here on a maybe.

There is no group program here, no twelve-step curriculum and no shared schedule. The facility holds three to five clients at a time — one only, on the Platinum Package — and every session each of them receives is delivered one-on-one, in a private room with a private bathroom. In benzodiazepine work that matters more than anywhere else: two people on an identical reduction schedule is a coincidence, not a protocol. It also means a taper can be slowed at four in the morning without a committee, and that the staff working with a guest in week six are the same people who admitted them in week one.

That scale is deliberate and it is the reason we can do this the way we do. A larger census would force a standard reduction schedule, because no facility can individually adjust forty tapers at four in the morning. I would rather admit fewer people and get each reduction right than run a bigger program on a printed protocol.

What Brought Me to This Work

I am not a physician, and I have never presented myself as one. I don’t diagnose and I don’t prescribe. What I do is design the protocol, lead the healing side of this work, and stay personally involved in every case at this facility. In fifteen years of operation there has been no guest death at this facility. I state that once, plainly, because it’s true and because it is the direct result of the screening and staffing decisions on this page — never as a guarantee about your own outcome, which no honest program can offer anyone.

Why We Don’t Have Outside Trial Data — and Why That’s a Real Trade-Off

We are independently funded. We take no government, institutional or pharmaceutical money, and I have made a deliberate choice not to license this protocol to outside researchers. I make that choice with full awareness of what it costs: the kind of third-party clinical trial data that larger, funded programs can point to. I’d rather be honest about that trade-off than pretend it doesn’t exist. What I can offer instead is fifteen years of doing this work openly, under our own name, and a founder who is still in the building.

What We Do Not Claim About Benzodiazepine Detox for New York Residents

Nothing described on this page has been evaluated by the FDA, and Holistic Sanctuary does not diagnose, treat or cure disease.

We do not publish a success rate, because we have not run the kind of study that would let us calculate one honestly.

Individual results vary, and some people need longer than twelve weeks. Protracted symptoms after benzodiazepine discontinuation are real and well documented, and anyone telling you a residential stay guarantees they will not occur is not being straight with you.

What we will tell you honestly, before you book, is whether we think this model fits your situation. A meaningful share of inquiries end with us saying no — and I would rather place you correctly than place you here.

Frequently Asked Questions

How long does benzodiazepine detox for New York residents take?

Programs here run four to twelve weeks, and longer when a taper needs it. We do not run a five-to-seven-day detox. Some stays run longer when the clinical picture calls for it, and we would rather extend a stay than meet a date.

Can I reduce a benzodiazepine on my own at home?

No. Stopping abruptly, or reducing too quickly without medical supervision, can cause seizures and other life-threatening complications. Any change to your dose should be decided and supervised by a physician.

Does New Yorks Prescription Monitoring Program affect my ability to get help?

It does not disqualify anyone from treatment. Since 27 August 2013 most New York prescribers have been required to consult the PMP Registry before prescribing Schedule II, III or IV controlled substances, which includes benzodiazepines. Being on a monitored prescription is a record, not a mark against you.

Will I be switched to a different medication?

No. Nobody leaves here on a maintenance prescription for something else, and nobody is moved sideways onto a longer-acting benzodiazepine they will have to come off somewhere else later. Medication-free is the destination.

Is NAD the Brain Repair Protocol?

No. NAD is a supportive therapy here. The Brain Repair IV Protocol is a proprietary formulation of amino acids, peptides and a nature-derived alkaloid, sequenced and dosed to the individual under nursing supervision, and it is documented on its own page.

What does the FDA say about benzodiazepine dependence?

The 2020 boxed-warning update states that physical dependence can develop within several days to weeks of steady use at prescribed doses, that abrupt discontinuation or rapid dose reduction can cause life-threatening withdrawal reactions including seizures, and that withdrawal symptoms can persist for weeks to more than twelve months.

Are protracted withdrawal symptoms permanent?

Protracted symptoms after benzodiazepine discontinuation are real and documented. They are not a sign that someone is doing it wrong, and we will not tell you a residential stay guarantees they will not occur.

Read Next

• Benzodiazepine recovery: the full program
• Benzodiazepine withdrawal: the three rules of a safe taper
• Benzodiazepine treatment: four facts before you choose
• The Brain Repair IV Protocol

References

1. U.S. Food and Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. Drug Safety Communication, 23 September 2020.
2. New York State Department of Health. Prescription Monitoring Program Registry. Mandatory prescriber consultation effective 27 August 2013.
3. Ashton CH. Benzodiazepines: How They Work and How to Withdraw (the Ashton Manual). Newcastle University, revised 2002.
4. Ritvo AD, Foster DE, Huff C, et al. Long-term consequences of benzodiazepine-induced neurological dysfunction: a survey. PLOS ONE 2023;18(6):e0285584.
5. Undersea and Hyperbaric Medical Society. Approved indications for hyperbaric oxygen therapy.
6. Systematic review and dosage analysis: hyperbaric oxygen therapy efficacy in the treatment of posttraumatic stress disorder. Frontiers in Neurology 2024;15:1360311.
7. Field T, Hernandez-Reif M, Diego M, Schanberg S, Kuhn C. Cortisol decreases and serotonin and dopamine increase following massage therapy. International Journal of Neuroscience 2005;115(10):1397–1413.
8. Laukkanen T, et al. Association between sauna bathing and fatal cardiovascular and all-cause mortality events. JAMA Internal Medicine 2015;175(4):542–548.
9. Riley KE, Park CL. How does yoga reduce stress? A systematic review of mechanisms of change and guide to future inquiry. Health Psychology Review 2015;9(3):379–396.

This page is educational and is not medical advice. Johnny Tabaie is the founder and CEO of Holistic Sanctuary and the creator of the Pouyan Method. He is not a physician and does not practice medicine. Every clinical statement here is reviewed by Dr. Jose A. Jimenez, MD before it publishes. The research cited describes general findings from published studies and does not represent outcomes data for this facility or a promise for any individual guest. Do not start, stop or change a benzodiazepine dose without the guidance of a qualified clinician.